| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 53-43-0 | 去氫表雄酮; 脫氫表雄甾酮 | Dehydroepiandrosterone; DHEA; Prasterone; AndrOstenolone; Dehydroisoandrosterone; trans-Dehydroandrosterone; Hydroxyandrost-5-en-17-one |  | C19H28O2 | 詳情 | 供應(yīng)商 |
| 54276-21-0 | (+)-氯前列烯醇; (5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-氯苯氧基)-3-羥基-1-丁烯-1-基]-3,5-二羥基環(huán)戊基] | (+)-CloprOstenol; (5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid |  | C22H29ClO6 | 詳情 | 供應(yīng)商 |
| 55028-72-3 | 氯前列烯醇鈉; 7-[2-[4-(3-氯苯氧基)-3-羥基丁-1-烯基]-3,5-二羥基環(huán)戊基]庚-5-烯酸鈉 | CloprOstenol sodium; Sodium [1alpha(Z),2beta(1E,3R*),3alpha,5alpha]-(+/-)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate |  | C22H28ClNaO6 | 詳情 | 供應(yīng)商 |
| 120813-22-1 | Estr-4-en-3-one-16,16,17-d3,17-hydroxy-, (17b)-(9CI); 19-NORTESTOSTERONE (16,16,17-D3); NANDROLONE-16,16,17-D3; NANDROLONE-D3; 17b-Hydroxy-4-estren-3-one-d3; 19-Nortestosterone-d3; (17)-17-Hydroxyestr-4-en-3-one-d3; 17-Hydroxy-19-nor-4-androsten-3-one-d3; 19-NorandrOstenolone-d3 |  | C18H23D3O2 | 詳情 | 供應(yīng)商 | |
| 516-78-9 | Ergost-7-en-3-ol, (3b,5a)-; 5a-Ergost-7-en-3b-ol (6CI,7CI,8CI); (24S)-24-Methyl-5a-cholest-7-en-3b-ol; (24S)-Ergost-7-en-3b-ol; 7-ErgOstenol; Fungisterol; D7-Campestenol; D7-Campesterol; g-ErgOstenol |  | C28H48O | 詳情 | 供應(yīng)商 | |
| 104987-51-1 | Lanost-8-en-3-ol,25-amino-, (3b)-(9CI); 25-Aminodihydrolanosterol; 25-AminolanOstenol |  | C30H53NO | 詳情 | 供應(yīng)商 | |
| 6890-88-6 | Lanost-8-en-3-ol,24-methylene-, (3b)-; Lanost-8-en-3b-ol, 24-methylene- (7CI,8CI); Obtusifoldienol (6CI); 24-Methylene-24,25-dihydrolanosterol; 24-Methylenedihydrolanosterol; 24-Methylenelanost-8-en-3b-ol; 24-MethylenelanOstenol; Eburicol |  | C31H52O | 詳情 | 供應(yīng)商 | |
| 35121-78-9 | 依前列醇; 依前列醇; (5Z,9Α,11Α,13E,15S)-6,9-環(huán)氧-11,15-二羥基前列-5,13-二烯-1-酸; 前列環(huán)素 | Prosta-5,13-dien-1-oicacid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9a,11a,13E,15S)-; 2H-Cyclopenta[b]furan,prosta-5,13-dien-1-oic acid deriv.; 6(9)-Oxy-11,15-dihydroxyprosta-5,13-dienoicacid; EpoprOstenol; PGI2; PGX; PGX (prostaglandin); Prostacyclin; ProstaglandinI; Prostaglandin I2; Prostaglandin X; U 53217; Vasocyclin |  | C20H32O5 | 詳情 | 供應(yīng)商 |
| 206555-98-8 | CloprOstenol | 無 | C27H46O | 詳情 | 供應(yīng)商 | |
| 61849-14-7 | 依前列醇鈉 | PROSTACYCLIN SODIUM SALT; EPOPROstenol; EPOPROstenol SODIUM; EPOPROstenol SODIUM SALT; (5-Z)-9-DEOXY-6,9ALPHA-EPOXY-PGF1ALPHA, SODIUM SALT; [5Z,9ALPHA,11ALPHA,13E,15S]-6,9-EPOXY-11,15-DIHYDROXYPROSTA-5,13-DIEN-1-OIC ACID SODIUM SALT; 6,9ALPHA-EPOXY-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID, SODIUM SALT; PROSTACYCLINE SODIUM SALT; PROSTACYCLIN SODIUM SALT |  | C20H31NaO5 | 詳情 | 供應(yīng)商 |
| 53872-60-9 | (+)-(3AR,4R,5R,6AS)-六氫-5-羥基-4-[(1E,3R)-3-羥基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-環(huán)戊并[B]呋喃-2- | (+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]; (+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE; (+)-FLUPROstenol LACTONE DIOL; (+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE; HYDRIDE-T; (+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-one; TP-2 (TV-EDI) (Travoprost) |  | C18H19F3O5 | 詳情 | 供應(yīng)商 |